Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
HTS_TST |
By Key Population: FSW, Negative |
2018 |
5,822 |
HTS_TST |
By Key Population: MSM, Negative |
2018 |
2,128 |
HTS_TST |
By Key Population: People in prisons and other enclosed settings, Negative |
2018 |
1,134 |
HTS_TST |
By Key Population: PWID, Negative |
2018 |
24,993 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2018 |
35,686 |
HTS_TST |
Service Delivery Point Agg Age (Community) Mobile Testing: 15+, Male, Negative |
2018 |
1,260 |
HTS_TST |
Service Delivery Point Agg Age (Community) Other: 15+, Female, Negative |
2018 |
1,388 |
HTS_TST |
Service Delivery Point Agg Age (Community) Other: 15+, Male, Negative |
2018 |
5,496 |
HTS_TST |
Service Delivery Point Agg Age (Community) VCT Mod: 15+, Female, Negative |
2018 |
5,558 |
HTS_TST |
Service Delivery Point Agg Age (Community) VCT Mod: 15+, Male, Negative |
2018 |
21,984 |
HTS_TST |
Sum of Test Result disaggregates |
2018 |
1,609 |
HTS_TST_POS |
By Key Population: FSW, Positive |
2018 |
191 |
HTS_TST_POS |
By Key Population: MSM, Positive |
2018 |
67 |
HTS_TST_POS |
By Key Population: People in prisons and other enclosed settings, Positive |
2018 |
126 |
HTS_TST_POS |
By Key Population: PWID, Positive |
2018 |
1,225 |
HTS_TST_POS |
By Test Result: Positive |
2018 |
1,609 |
HTS_TST_POS |
Service Delivery Point Agg Age (Community) Mobile Testing: 15+, Male, Positive |
2018 |
126 |
HTS_TST_POS |
Service Delivery Point Agg Age (Community) Other: 15+, Female, Positive |
2018 |
47 |
HTS_TST_POS |
Service Delivery Point Agg Age (Community) Other: 15+, Male, Positive |
2018 |
248 |
HTS_TST_POS |
Service Delivery Point Agg Age (Community) VCT Mod: 15+, Female, Positive |
2018 |
190 |
HTS_TST_POS |
Service Delivery Point Agg Age (Community) VCT Mod: 15+, Male, Positive |
2018 |
998 |
KP_MAT |
Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months |
2018 |
5,509 |
KP_MAT |
Sex: Female |
2018 |
209 |
KP_MAT |
Sex: Male |
2018 |
5,300 |
KP_MAT |
Sum of Sex Disaggregates |
2018 |
5,509 |
KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
6,315 |
KP_PREV |
By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
1,063 |
KP_PREV |
By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
27,247 |
KP_PREV |
By key population type: Men who have sex with men and are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
2,324 |
KP_PREV |
By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
1,260 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2018 |
38,209 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2018 |
424 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2018 |
2,594 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2018 |
3,018 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2018 |
3,018 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2018 |
3,018 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2018 |
266 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2018 |
1,712 |
TX_NEW |
By Key populations: People who inject drugs (PWID) |
2018 |
1,633 |
TX_NEW |
FSW |
2018 |
171 |
TX_NEW |
MSM |
2018 |
67 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2018 |
1,978 |
TX_NEW |
People in prisons and other enclosed settings |
2018 |
107 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2018 |
1,978 |
TX_RET |
Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2018 |
146 |
TX_RET |
Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2018 |
962 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2018 |
1,108 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2018 |
1,228 |
TX_RET_den |
Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2018 |
159 |
TX_RET_den |
Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2018 |
1,069 |